Category: Diseases & Conditions
Diseases & Conditions market research reports by The Insight Partners
-
Contract Research Organization Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Early Phase Development Services, Clinical Research Services, Laboratory Services, and Post-Approval Services), Product Type (Cell and Gene Therapy, Biosimilars, Antibody Drug Conjugates, and Others), Type (In-house and Outsource), Application (Oncology, Neurology, Cardiology, Infectious Diseases, Metabolic Disorder, Nephrology, Respiratory, Dermatology, Ophthalmology, Hematology, and Others), End User (Pharmaceutical and Biotech Companies, Medical Device Companies, Academic and Research Institutes, and Others) and Geography
The contract research organization market is expected to reach US$ 113.79 billion by 2031 from US$ 65.38 billion in 2024; the market is estimated to grow at a CAGR of 8.2% during 2025–2031. Major factors driving the market growth include increased outsourcing of R&D and rising demand for clinical tr ... Read More
-
Europe Contract Research Organization Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Early Phase Development Services, Clinical Research Services, Laboratory Services, and Post-Approval Services), Product type (Cell and Gene Therapy, Biosimilars, Antibody Drug Conjugates, and Others), Type (In-house and Outsource), Application (Oncology, Neurology, Cardiology, Infectious Diseases, Metabolic Disorder, Nephrology, Respiratory, Dermatology, Ophthalmology, Hematology and Others), and End User (Pharmaceutical and Biotech Companies, Medical Device Companies, and Academic and Research Institutes)
The Europe Contract Research Organization Market is expected to reach US$ 40.02 billion by 2031 from US$ 22.88 billion in 2024. The market is estimated to grow with a CAGR of 8.3% from 2025 to 2031. The Europe Contract Research Organization market forecast presented in this report can help stakehold ... Read More
-
North America Intermittent Catheters Market Forecast to 2031 - Regional Analysis - by Product (Coated Intermittent Catheters and Uncoated Intermittent Catheters), Indication [Urinary Incontinence, General Surgeries, Spinal Cord Injuries, Parkinson's Disease (PD), Multiple Sclerosis, and Others], Category (Female Length Catheters, Male Length Catheters, and Kid Length Catheters), System Type (Closed Intermittent Catheters Systems and Open Intermittent Catheters Systems), and End User (Hospitals, Ambulatory Surgical Centers, Home Care Settings, and Others)
The North America intermittent catheters market was valued at US$ 1,035.79 million in 2023 and is expected to reach US$ 1,506.64 million by 2031; it is estimated to register a CAGR of 4.8% from 2023 to 2031. Surging Prevalence of Urinary Incontinence Fuels North America Intermittent Catheters Market ... Read More
-
South & Central America Intermittent Catheters Market Forecast to 2031 - Regional Analysis - by Product (Coated Intermittent Catheters and Uncoated Intermittent Catheters), Indication [Urinary Incontinence, General Surgeries, Spinal Cord Injuries, Parkinson's Disease (PD), Multiple Sclerosis, and Others], Category (Female Length Catheters, Male Length Catheters, and Kid Length Catheters), System Type (Closed Intermittent Catheters Systems and Open Intermittent Catheters Systems), and End User (Hospitals, Ambulatory Surgical Centers, Home Care Settings, and Others)
The South & Central America intermittent catheters market was valued at US$ 139.66 million in 2023 and is expected to reach US$ 186.56 million by 2031; it is estimated to register a CAGR of 3.7% from 2023 to 2031. Growing Preference for Self-Catheterization and Increasing Investments in Urinary Cath ... Read More
-
South & Central America Blood Collection Tubes for Liquid Biopsy Market Forecast to 2031 - Regional Analysis - by Product (ccfDNA/cfDNA Tubes, cfRNA Tubes, CTC Tubes, gDNA Tubes, Intracellular RNA Tubes, and Others), Material (Plastic and Glass), Application [In-Vitro Diagnostics (IVD) and Research], and End User (Genetic Diagnostic Labs, Research and Development Centers, Conventional Diagnostic Centers, and Others)
The South & Central America blood collection tubes for liquid biopsy market was valued at US$ 3,304.16 million in 2023 and is expected to reach US$ 12,431.43 million by 2031; it is estimated to register a CAGR of 18.0% from 2023 to 2031. Use of Liquid Biopsy in Cancer Monitoring Fuels South & Centra ... Read More
-
Asia Pacific Medical Exoskeleton Market Forecast to 2031 - Regional Analysis - by Component (Hardware and Software), Type (Powered Exoskeleton and Passive Exoskeleton), Extremity (Lower Body Exoskeleton, Upper Body Exoskeleton, and Full Body Exoskeleton), Application (Spinal Cord Injury, Multiple Sclerosis, Stroke, Cerebral Palsy, Parkinson's Disease, and Others), Mobility (Mobile Exoskeleton and Stationary Exoskeleton), and End Users (Rehabilitation Centers, Physiotherapy Centers, Long Term Care Centers, Homecare Settings, and Others)
The Asia Pacific medical exoskeleton market was valued at US$ 76.43 million in 2023 and is expected to reach US$ 720.20 million by 2031; it is estimated to register a CAGR of 32.4% from 2023 to 2031. Increasing Prevalence of SCI Boosts Asia Pacific Medical Exoskeleton Market Reduced physical activit ... Read More
-
South & Central America Medical Exoskeleton Market Forecast to 2031 - Regional Analysis - by Component (Hardware and Software), Type (Powered Exoskeleton and Passive Exoskeleton), Extremity (Lower Body Exoskeleton, Upper Body Exoskeleton, and Full Body Exoskeleton), Application (Spinal Cord Injury, Multiple Sclerosis, Stroke, Cerebral Palsy, Parkinson's Disease, and Others), Mobility (Mobile Exoskeleton and Stationary Exoskeleton), and End Users (Rehabilitation Centers, Physiotherapy Centers, Long Term Care Centers, Homecare Settings, and Others)
The South & Central America medical exoskeleton market was valued at US$ 17.51 million in 2023 and is expected to reach US$ 134.09 million by 2031; it is estimated to register a CAGR of 29.0% from 2023 to 2031. Increasing Prevalence of SCI Fuels South & Central America Medical Exoskeleton Market Red ... Read More
-
Middle East & Africa Intermittent Catheters Market Forecast to 2031 - Regional Analysis - by Product (Coated Intermittent Catheters and Uncoated Intermittent Catheters), Indication [Urinary Incontinence, General Surgeries, Spinal Cord Injuries, Parkinson's Disease (PD), Multiple Sclerosis, and Others], Category (Female Length Catheters, Male Length Catheters, and Kid Length Catheters), System Type (Closed Intermittent Catheters Systems and Open Intermittent Catheters Systems), and End User (Hospitals, Ambulatory Surgical Centers, Home Care Settings, and Others)
The Middle East & Africa intermittent catheters market was valued at US$ 127.81 million in 2023 and is expected to reach US$ 165.33 million by 2031; it is estimated to register a CAGR of 3.3% from 2023 to 2031. Micro-Hole Zone Catheters Bolster Middle East & Africa Intermittent Catheters Market UTIs ... Read More
-
Europe Medical Exoskeleton Market Forecast to 2031 - Regional Analysis - by Component (Hardware and Software), Type (Powered Exoskeleton and Passive Exoskeleton), Extremity (Lower Body Exoskeleton, Upper Body Exoskeleton, and Full Body Exoskeleton), Application (Spinal Cord Injury, Multiple Sclerosis, Stroke, Cerebral Palsy, Parkinson's Disease, and Others), Mobility (Mobile Exoskeleton and Stationary Exoskeleton), and End Users (Rehabilitation Centers, Physiotherapy Centers, Long Term Care Centers, Homecare Settings, and Others)
The Europe medical exoskeleton market was valued at US$ 107.48 million in 2023 and is expected to reach US$ 853.96 million by 2031; it is estimated to register a CAGR of 29.6% from 2023 to 2031. Growing Incidence of Stroke and Musculoskeletal Drives Europe Medical Exoskeleton Market Despite the adva ... Read More
-
Middle East & Africa Medical Exoskeleton Market Forecast to 2031 - Regional Analysis - by Component (Hardware and Software), Type (Powered Exoskeleton and Passive Exoskeleton), Extremity (Lower Body Exoskeleton, Upper Body Exoskeleton, and Full Body Exoskeleton), Application (Spinal Cord Injury, Multiple Sclerosis, Stroke, Cerebral Palsy, Parkinson's Disease, and Others), Mobility (Mobile Exoskeleton and Stationary Exoskeleton), and End Users (Rehabilitation Centers, Physiotherapy Centers, Long Term Care Centers, Homecare Settings, and Others)
The Middle East & Africa medical exoskeleton market was valued at US$ 14.19 million in 2023 and is expected to reach US$ 98.25 million by 2031; it is estimated to register a CAGR of 27.4% from 2023 to 2031. Increasing Technological Advancements and Rising Investments Bolster Middle East & Africa Med ... Read More
-
North America Medical Exoskeleton Market Forecast to 2031 - Regional Analysis - by Component (Hardware and Software), Type (Powered Exoskeleton and Passive Exoskeleton), Extremity (Lower Body Exoskeleton, Upper Body Exoskeleton, and Full Body Exoskeleton), Application (Spinal Cord Injury, Multiple Sclerosis, Stroke, Cerebral Palsy, Parkinson's Disease, and Others), Mobility (Mobile Exoskeleton and Stationary Exoskeleton), and End Users (Rehabilitation Centers, Physiotherapy Centers, Long Term Care Centers, Homecare Settings, and Others)
The North America medical exoskeleton market was valued at US$ 159.30 million in 2023 and is expected to reach US$ 1,400.25 million by 2031; it is estimated to register a CAGR of 31.2% from 2023 to 2031. Rising Number of Strategic Initiatives Fuels North America Medical Exoskeleton Market Small and ... Read More
-
Asia Pacific Intermittent Catheters Market Forecast to 2031 - Regional Analysis - by Product (Coated Intermittent Catheters and Uncoated Intermittent Catheters), Indication [Urinary Incontinence, General Surgeries, Spinal Cord Injuries, Parkinson's Disease (PD), Multiple Sclerosis, and Others], Category (Female Length Catheters, Male Length Catheters, and Kid Length Catheters), System Type (Closed Intermittent Catheters Systems and Open Intermittent Catheters Systems), and End User (Hospitals, Ambulatory Surgical Centers, Home Care Settings, and Others)
The Asia Pacific intermittent catheters market was valued at US$ 578.56 million in 2023 and is expected to reach US$ 854.68 million by 2031; it is estimated to register a CAGR of 5.0% from 2023 to 2031. Growing Preference for Self-Catheterization and Increasing Investments in Urinary Catheter Develo ... Read More
-
Europe Intermittent Catheters Market Forecast to 2031 - Regional Analysis - by Product (Coated Intermittent Catheters and Uncoated Intermittent Catheters), Indication [Urinary Incontinence, General Surgeries, Spinal Cord Injuries, Parkinson's Disease (PD), Multiple Sclerosis, and Others], Category (Female Length Catheters, Male Length Catheters, and Kid Length Catheters), System Type (Closed Intermittent Catheters Systems and Open Intermittent Catheters Systems), and End User (Hospitals, Ambulatory Surgical Centers, Home Care Settings, and Others)
The Europe intermittent catheters market was valued at US$ 791.79 million in 2023 and is expected to reach US$ 1,121.79 million by 2031; it is estimated to register a CAGR of 4.5% from 2023 to 2031. Adoption of Single-Use Catheters Drives Europe Intermittent Catheters Market Single-use intermittent ... Read More
-
Infusion Devices Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Infusion Pumps [Volumetric Pumps, Syringe Pumps, Insulin Pumps, Patient Control Analgesia (PCA) Pumps, Enteral Pumps, Implantable Pumps, and Elastomeric Pumps] and Infusion Sets [Vented Infusion Sets and Non-Vented Infusion Sets], Application (Diabetes, Oncology, Pain Management, Hematology, Pediatrics, Gastroenterology, and Others), End User (Hospitals and Specialty Clinics, Homecare Settings, Ambulatory Surgical Centers, and Others), and Geography
The infusion devices market is expected to reach US$ 23.08 billion by 2031 from US$ 13.73 billion in 2023; the market is estimated to grow at a CAGR of 6.7% during 2023–2031. Major factors driving the market growth include increasing prevalence of cancer and growing geriatric population. Further, st ... Read More
-
India Cystoscopy and Ureteroscopy Market Size and Forecast (2021 - 2031), Country Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Cystoscope, Ureteroscope, and Urology Camera), Procedure [Stone Management, Bladder Cancer, Benign Prostrate Hyperplasia (BPH), and Others], Technology (Fiber Optic, Video, and Others), Usage Type (Reusable and Single Use), and End User (Hospitals, Ambulatory Surgical Centers, and Specialty Centers)
The India cystoscopy and ureteroscopy market expected to grow from US$ 180.00 million in 2023 to US$ 313.63 million by 2031; it is estimated to register a CAGR of 7.2% from 2023 to 2031. Factors such as increasing prevalence of urological diseases, and development of technologically advanced and min ... Read More
-
Middle East & Africa Pharmacokinetics Services Market Forecast to 2031 - Regional Analysis - by Drug Type (Small Molecule, Large Molecule, and Vaccines), Service Type (Pre-Clinical ADME and Human Studies, PK/PD Analysis and Reporting, Dosing Simulations, Risk Analysis, and Others), Therapeutic Application (Oncology, Infectious Diseases, Neurological Disorders, Autoimmune Diseases, Gynecological Disorders, Cardiovascular Diseases, Respiratory Disorders, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others)
Middle East & Africa Pharmacokinetics Services Market Forecast to 2031 - Regional Analysis - by Drug Type (Small Molecule, Large Molecule, and Vaccines), Service Type (Pre-Clinical ADME and Human Studies, PK/PD Analysis and Reporting, Dosing Simulations, Risk Analysis, and Others), Therapeutic Appli ... Read More
-
North America Pharmacokinetics Services Market Forecast to 2031 - Regional Analysis - by Drug Type (Small Molecule, Large Molecule, and Vaccines), Service Type (Pre-Clinical ADME and Human Studies, PK/PD Analysis and Reporting, Dosing Simulations, Risk Analysis, and Others), Therapeutic Application (Oncology, Infectious Diseases, Neurological Disorders, Autoimmune Diseases, Gynecological Disorders, Cardiovascular Diseases, Respiratory Disorders, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others)
North America Pharmacokinetics Services Market Forecast to 2031 - Regional Analysis - by Drug Type (Small Molecule, Large Molecule, and Vaccines), Service Type (Pre-Clinical ADME and Human Studies, PK/PD Analysis and Reporting, Dosing Simulations, Risk Analysis, and Others), Therapeutic Application ... Read More
-
South & Central America Pharmacokinetics Services Market Forecast to 2031 - Regional Analysis - by Drug Type (Small Molecule, Large Molecule, and Vaccines), Service Type (Pre-Clinical ADME and Human Studies, PK/PD Analysis and Reporting, Dosing Simulations, Risk Analysis, and Others), Therapeutic Application (Oncology, Infectious Diseases, Neurological Disorders, Autoimmune Diseases, Gynecological Disorders, Cardiovascular Diseases, Respiratory Disorders, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others)
South & Central America Pharmacokinetics Services Market Forecast to 2031 - Regional Analysis - by Drug Type (Small Molecule, Large Molecule, and Vaccines), Service Type (Pre-Clinical ADME and Human Studies, PK/PD Analysis and Reporting, Dosing Simulations, Risk Analysis, and Others), Therapeutic Ap ... Read More
-
Asia Pacific Pharmacokinetics Services Market Forecast to 2031 - Regional Analysis - by Drug Type (Small Molecule, Large Molecule, and Vaccines), Service Type (Pre-Clinical ADME and Human Studies, PK/PD Analysis and Reporting, Dosing Simulations, Risk Analysis, and Others), Therapeutic Application (Oncology, Infectious Diseases, Neurological Disorders, Autoimmune Diseases, Gynecological Disorders, Cardiovascular Diseases, Respiratory Disorders, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others)
Asia Pacific Pharmacokinetics Services Market Forecast to 2031 - Regional Analysis - by Drug Type (Small Molecule, Large Molecule, and Vaccines), Service Type (Pre-Clinical ADME and Human Studies, PK/PD Analysis and Reporting, Dosing Simulations, Risk Analysis, and Others), Therapeutic Application ( ... Read More
-
Europe Pharmacokinetics Services Market Forecast to 2031 - Regional Analysis - by Drug Type (Small Molecule, Large Molecule, and Vaccines), Service Type (Pre-Clinical ADME and Human Studies, PK/PD Analysis and Reporting, Dosing Simulations, Risk Analysis, and Others), Therapeutic Application (Oncology, Infectious Diseases, Neurological Disorders, Autoimmune Diseases, Gynecological Disorders, Cardiovascular Diseases, Respiratory Disorders, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others)
Europe Pharmacokinetics Services Market Forecast to 2031 - Regional Analysis - by Drug Type (Small Molecule, Large Molecule, and Vaccines), Service Type (Pre-Clinical ADME and Human Studies, PK/PD Analysis and Reporting, Dosing Simulations, Risk Analysis, and Others), Therapeutic Application (Oncolo ... Read More
-
South & Central America Epilepsy Market Forecast to 2030 - Regional Analysis - by Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First Generation Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others)
South & Central America Epilepsy Market Forecast to 2030 - Regional Analysis - by Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First Generation Drugs, Second Generation Drugs, and Thir ... Read More
-
North America Epilepsy Market Forecast to 2030 - Regional Analysis - by Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First Generation Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others)
North America Epilepsy Market Forecast to 2030 - Regional Analysis - by Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First Generation Drugs, Second Generation Drugs, and Third Generati ... Read More
-
Europe Epilepsy Market Forecast to 2030 - Regional Analysis - by Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First Generation Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others)
Europe Epilepsy Market Forecast to 2030 - Regional Analysis - by Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First Generation Drugs, Second Generation Drugs, and Third Generation Drug ... Read More
-
Middle East & Africa Epilepsy Market Forecast to 2030 - Regional Analysis - by Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First Generation Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others)
Middle East & Africa Epilepsy Market Forecast to 2030 - Regional Analysis - by Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First Generation Drugs, Second Generation Drugs, and Third G ... Read More
-
Asia Pacific Epilepsy Market Forecast to 2030 - Regional Analysis - by Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First Generation Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others)
Asia Pacific Epilepsy Market Forecast to 2030 - Regional Analysis - by Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First Generation Drugs, Second Generation Drugs, and Third Generatio ... Read More
Research Assistance
